Early Platform Contractor

Cibus; San Diego (CA); On-site; USD 29,000 - 34,000; Full time

Job summary

Cibus in San Diego, CA is seeking an Early Platform contractor to support plant cell biology workflows across laboratory, greenhouse, and warehouse settings. This temporary role lasts three to four months and requires reliable, proactive, and collaborative work.

Responsibilities include generating plants from cell/tissue cultures, germination, micropropagation, protoplast isolation, tissue sampling for screening, maintaining records, and training new hires; follow SOPs and implement quality

Qualifications

• Experience with aseptic techniques and cell cultures.
• Understanding of molecular biology techniques including cloning and PCR.
• Familiarity with functional assays in yeast or plant systems.

Responsibilities

• Generate plants from cell/tissue cultures in the cell biology trait production pipeline, including in vitro germination and micropropagation, microspore culture for haploid plants, protoplast isolation and culture, shoot regeneration, tissue sampling for molecular screening and QC, and delivery of plants from lab to product development.
• Maintain lab notebooks and electronic files, implement LIMS, and aid database development.
• Provide training and coaching for new hires.
• Follow SOPs, troubleshoot, and implement robust quality controls to minimize production loss and maintain efficient processes.

Skills

Aseptic techniques

Molecular cloning & PCR

Yeast/plant assays

Job description

Cibus is a biotechnology company with advanced technologies to precisely target and direct a plant’s natural gene-editing processes. This approach accelerates natural plant breeding that has been a staple of farming for thousands of years and has resulted in a rapid, versatile and low-cost way to produce sustainable industrial and agricultural products and improve human health by safely harnessing nature’s own genetic diversity.

The company has a worldwide presence, with subsidiaries in Europe and North America and a state-of-the-art research and development center in San Diego, CA. Cibus has a pipeline of traits for canola and rice and is developing crop platforms and a pipeline of trait products in other major global crops including soybean, wheat and corn. The broad applicability of Cibus’ technologies is highlighted by the company’s strain-advancement program, which develops sustainable products in microbial platforms for food, flavor and fragrance, and personal care markets.

• Experience working with aseptic techniques and cell cultures.
• Understanding and some practical experience with a range of molecular biology technologies including molecular cloning, PCR and other DNA manipulations is desirable.
• Familiarity with functional assays in yeast and/or plant systems is beneficial.

Cibus has an immediate opening for an Early Platform contractor. This role will work across a variety of facilities including biotechnology laboratory settings, greenhouse, and warehouse environments. This position calls for a highly reliable, proactive, and collaborative individual. This role is temporary and is expected to last three to four months.

• Participate in the day-to-day responsibilities for the generation of plants from cell/tissue cultures in the cell biology trait production pipeline, including in vitro germination and micropropagation, microspore culture for generation of haploid plants, protoplast isolation and culture, shoot regeneration, tissue sampling for molecular screening and QC, propagation and delivery of selected plants from the lab to product development.
• Maintain lab notebooks and electronic files up to date and implement laboratory information managing systems and participate in the development of databases.
• Provide training and coaching for new hires.
• Follow SOPs, help troubleshooting and implement robust quality controls to ensure minimal production loss and maintain efficient processes.

Salary Range:

$21.00 - $25.00/hour

ONLY CANDIDATES WITH WORK AUTHORIZATION IN THE U.S. ARE CONSIDERED AT THIS TIME.